enGene Ownership | Who Owns enGene?
enGene Ownership Summary
enGene is owned by 33.18% institutional investors, 0.09% insiders, and 66.73% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 18.85% of ENGN shares.
ENGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | enGene | 33.18% | 0.09% | 66.73% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.63M | 18.85% | $65.79M |
| Vr adviser | 5.05M | 9.88% | $34.47M |
| Kynam capital management, lp | 4.99M | 9.77% | $34.11M |
| Blue owl capital lp | 3.36M | 6.55% | $30.35M |
| Cormorant asset management, lp | 2.32M | 4.55% | $15.87M |
| Braidwell lp | 2.27M | 4.44% | $15.48M |
| Deep track capital, lp | 2.24M | 4.38% | $15.29M |
| Perceptive advisors | 2.10M | 4.10% | $14.32M |
| Franklin resources | 1.39M | 2.71% | $12.53M |
| Point72 asset management | 1.21M | 2.36% | $8.25M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.63M | 13.15% | $65.79M |
| Kynam capital management, lp | 4.99M | 2.54% | $34.11M |
| Blue owl capital lp | 3.36M | 2.27% | $30.35M |
| Vr adviser | 5.05M | 1.94% | $34.47M |
| Omega fund management | 526.36K | 1.62% | $3.60M |
| Monashee investment management | 295.00K | 1.50% | $2.66M |
| Cormorant asset management, lp | 2.32M | 1.10% | $15.87M |
| Sr one capital management, lp | 747.75K | 0.96% | $6.75M |
| Sphera funds management | 504.41K | 0.73% | $3.45M |
| Bioimpact capital | 530.30K | 0.59% | $3.62M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | 2.27M | 0.46% | 2.27M |
| Perceptive advisors | 2.10M | 0.41% | 2.10M |
| Bioimpact capital | 530.30K | 0.59% | 530.30K |
| Privium fund management b.v. | 352.09K | 0.59% | 352.09K |
| Franklin resources | 1.39M | 0.00% | 350.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 2.24M | 0.43% | -2.32M |
| Frazier life sciences management | - | - | -1.16M |
| Orbimed advisors | - | - | -677.98K |
| Schonfeld strategic advisors | 25.07K | 0.00% | -149.50K |
| Adar1 capital management | - | - | -27.79K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 2.27M | 0.46% | 2.27M | $15.48M |
| Perceptive advisors | 2.10M | 0.41% | 2.10M | $14.32M |
| Bioimpact capital | 530.30K | 0.59% | 530.30K | $3.62M |
| Privium fund management b.v. | 352.09K | 0.59% | 352.09K | $3.18M |
| Monashee investment management | 295.00K | 1.50% | 295.00K | $2.66M |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -380.00 |
| Wolverine asset management | -6.36K |
| Paloma partners management | -10.32K |
| Hudson bay capital management lp | -11.07K |
| Sectoral asset management | -11.70K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 27 | -28.95% | 17,021,462 | -58.35% | 33 | 0.52% | 21 | 50.00% | 2 | -75.00% |
| Sep 30, 2025 | 38 | 2.70% | 40,868,497 | 1.11% | 79 | 1.27% | 14 | 7.69% | 8 | -11.11% |
| Jun 30, 2025 | 37 | 19.35% | 40,420,485 | -1.27% | 79 | 1.23% | 13 | 44.44% | 9 | 12.50% |
| Mar 31, 2025 | 31 | -8.82% | 40,941,351 | -0.88% | 80 | 1.22% | 9 | -59.09% | 8 | 14.29% |
| Dec 31, 2024 | 34 | 13.33% | 41,304,528 | 20.44% | 81 | 1.34% | 22 | 37.50% | 7 | 75.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.00M |
| Oct 07, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $77.53K |
| Oct 04, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $39.24K |
| Oct 03, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $37.40K |
| Oct 08, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 7 | - |
| 2024 Q3 | 4 | - |
ENGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools